RAPT — Rapt Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Rapt Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	112	190	249	159	231
Prepaid Expenses
Total Current Assets	116	193	253	162	235
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.98	2.74	9.48	7.68	4.7
Other Long Term Assets
Total Assets	119	199	266	173	240
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.7	9.6	14.2	21.8	48.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	14.8	12.3	21	26.3	50.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	104	186	245	147	190
Total Liabilities & Shareholders' Equity	119	199	266	173	240
Total Common Shares Outstanding